Patient-Reported Treatment Satisfaction With Rivaroxaban for Stroke Prevention in Atrial Fibrillation. A French Observational Study, the SAFARI Study

PLoS ONE - United States
doi 10.1371/journal.pone.0166218
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation – A Multinational Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The ATRIA Study

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2009English

Stroke Prevention in Atrial Fibrillation

Journal of Atrial Fibrillation
Cardiovascular MedicineCardiology
2010English

Stroke Prevention in Atrial Fibrillation

International Journal of Arrhythmia
2017English

Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2017English

Primary and Secondary Prevention of Stroke and Systemic Embolism With Rivaroxaban in Patients With Non-Valvular Atrial Fibrillation

Heart and Vessels
Cardiovascular MedicineCardiology
2018English

Stroke Prevention in Atrial Fibrillation Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
1991English

Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation

Cardiology Research and Practice
Cardiovascular MedicineCardiology
2012English

Transient Ischemic Attacks in Patients With Atrial Fibrillation: Implications for Secondary Prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy